On August 31, 2018 Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, reported that members of the Company’s management team will participate at two upcoming conferences in September (Press release, Atara Biotherapeutics, AUG 31, 2018, View Source [SID1234529438]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CAR-TCR Summit 2018

Isaac Ciechanover, M.D., the Company’s President and Chief Executive Officer, will participate in a session titled "Next Generation CAR-TCR Therapies: Executive Leaders’ Fireside Chat" on Thursday, September 6, 2018 at 9:30 a.m. EDT.
Dietmar Berger, M.D., Ph.D., the Company’s Global Head of Research and Development, will give a presentation on Wednesday, September 5, 2018 at 11:15 a.m. EDT. He will then participate in a panel discussion on Thursday, September 6, 2018 at 5:15 p.m. EDT. The conference will be held at the Seaport Hotel & World Trade Center in Boston, MA.

Morgan Stanley 16th Annual Global Healthcare Conference

Dr. Ciechanover will participate in a fireside chat on Wednesday, September 12, 2018 at 2:15 p.m. EDT. The conference will be held at the Grand Hyatt Hotel in New York, NY.
A live audio webcast of the fireside chat discussion at the Morgan Stanley Global Healthcare Conference will be available by visiting the Investors section of the Atara website. An archived replay of the webcast will be available on the Company’s website for 14 days following the live fireside chat discussion.